Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

AIMS: To evaluate three oligonucleotide primer pairs--two specific for 16S and 23S rRNA sequences of Burkholderia cepacia, and the third specific for internal transcribed spacer region of 16S-23S sequences of B gladioli--for the identification and differentiation of reference and clinical strains of these and other species. METHODS: The three primers sets were applied in polymerase chain reaction (PCR) to a collection of 177 clinical isolates submitted for identification from diagnostic laboratories as presumed B cepacia. RESULTS: At an annealing temperature of 63 degrees C, all eight B cepacia and four B gladioli reference strains reacted with their specific primers. B vandii was the only other species that was positive with both B cepacia primers but five Burkholderia or Ralstonia species reacted with one of these primers. Seventy eight isolates were typical of B cepacia in biochemical tests and 75 of these reacted with specific primers; three, however, were positive with the B gladioli primers. Fifteen asaccharolytic isolates were confirmed as B cepacia by PCR but other non-fermenting Gram negative species were negative with each of the primers. CONCLUSIONS: PCR using 16S rRNA sequences is recommended for identification of B cepacia that give atypical results in biochemical tests.

[1]  P. Vandamme,et al.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. , 1997, International journal of systematic bacteriology.

[2]  P. Lambert,et al.  Isolation from clinical sources of Burkholderia cepacia possessing characteristics of Burkholderia gladioli. , 1997, The Journal of antimicrobial chemotherapy.

[3]  P. Vandamme,et al.  Burkholderia cepacia: medical, taxonomic and ecological issues. , 1996, Journal of medical microbiology.

[4]  A. Arroliga,et al.  Empyema and bloodstream infection caused by Burkholderia gladioli in a patient with cystic fibrosis after lung transplantation. , 1996, The Pediatric infectious disease journal.

[5]  P. Hoffman,et al.  Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis , 1996, Journal of clinical microbiology.

[6]  I. Yano,et al.  Transfer of Two Burkholderia and An Alcaligenes Species to Ralstonia Gen. Nov. , 1995, Microbiology and immunology.

[7]  J. Phillips,et al.  Detection of Pseudomonas (Burkholderia) cepacia using PCR , 1995, Pediatric pulmonology.

[8]  C. Strathdee,et al.  Oligonucleotide primers designed to differentiate pathogenic pseudomonads on the basis of the sequencing of genes coding for 16S-23S rRNA internal transcribed spacers , 1995, Clinical and diagnostic laboratory immunology.

[9]  E. Wang,et al.  Phylogenetic evidence for the transfer of Pseudomonas cocovenenans (van Damme et al. 1960) to the genus Burkholderia as Burkholderia cocovenenans (van Damme et al. 1960) comb. nov. , 1995, International journal of systematic bacteriology.

[10]  T. Heulin,et al.  Polyphasic Taxonomy in the Genus Burkholderia Leading to an Emended Description of the Genus and Proposition of Burkholderia vietnamiensis sp. nov. for N2-Fixing Isolates from Rice in Vietnam , 1995 .

[11]  M. Noble,et al.  Xanthomonas maltophilia misidentified as Pseudomonas cepacia in cultures of sputum from patients with cystic fibrosis: a diagnostic pitfall with major clinical implications. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[12]  J. Govan,et al.  Multi-resistance isolates possessing characteristics of both Burkholderia (Pseudomonas) cepacia and Burkholderia gladioli from patients with cystic fibrosis. , 1994, The Journal of antimicrobial chemotherapy.

[13]  K. Komagata,et al.  Transfer of pseudomonas plantarii and Pseudomonas glumae to Burkholderia as Burkholderia spp. and description of Burkholderia vandii sp. nov , 1994 .

[14]  M. Dodd,et al.  Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis , 1993, The Lancet.

[15]  Takayuki Ezaki,et al.  Proposal of Burkholderia gen. nov. and Transfer of Seven Species of the Genus Pseudomonas Homology Group II to the New Genus, with the Type Species Burkholderia cepacia (Palleroni and Holmes 1981) comb. nov. , 1992, Microbiology and immunology.

[16]  R. Stern,et al.  Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis , 1990, The Lancet.

[17]  J. Christenson,et al.  Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis , 1989, Journal of clinical microbiology.

[18]  C. Pai,et al.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis , 1987, Journal of clinical microbiology.

[19]  B. Holmes The identification of Pseudomonas cepacia and its occurrence in clinical material. , 1986, The Journal of applied bacteriology.